Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Intraperitoneal Drug Delivery for Peritoneal Carcinomatosis: from Bench to Bedside

Outputs and Outcomes

Code

01G02916

Duration

01 January 2016 → 09 October 2021

Funding

Regional and community funding: Special Research Fund

Promotor

Wim Ceelen

Research disciplines

Medical and health sciences
- Morphological sciences
- Oncology
- Morphological sciences
- Oncology
- Biomarker discovery and evaluation
- Drug discovery and development
- Medicinal products
- Pharmaceutics
- Pharmacognosy and phytochemistry
- Pharmacology
- Pharmacotherapy
- Toxicology and toxinology
- Other pharmaceutical sciences
- Morphological sciences
- Oncology

Keywords

carcinomatosis intraperitoneal chemotherapy

Project description

The aim of this project is to contribute to the insights in the physiology of intraperitoneal drug delivery and to develop improved treatment methods for peritoneal carcinomatosis.

English

Dutch

English

Cookie settings

In addition to functional cookies which are necessary for the website to function, Ghent University uses non-functional cookies such as statistical cookies and social media cookies. These non-functional cookies can also be placed by third parties, for example to measure the use of the site or to share content on social media. Certain media are only available if you accept the cookies. You can set and modify your cookie preferences yourself. Find out what cookies we use and why in the Cookie Statement.

Analytics

AnalyticsWe'll collect information about your visit to our site. It helps us understand how the site is used – what's working, what might be broken and what we should improve.

Powered by